IQVIA Holdings | IQV - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Accenture USD 2.96B 6.78M 2026-03
Agilent USD 465M 11M 2026-03
Bruker USD 242.1M 5.1M 2026-03
Cardinal Health USD 1.51B 6M 2026-03
Celltrion KRW 9.32B 3.39B 2026-03
Charles River Laboratories USD 159.42M 36.71M 2026-03
Cigna USD 3.32B 291M 2026-03
Cognizant Technology Solutions USD 791M 15M 2026-03
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 351M 32M 2026-03
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Elevance Health USD 10.91B 309M 2025-12
Humana USD 3.36B 614M 2025-03
IBM USD 4.4B 1.42B 2026-03
Illumina USD 272M 11M 2026-03
Infosys INR 10.82B 10.32B 2025-12
Kangmei Pharma CNY 237.06M 37.35M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Laboratory Of America USD 551M 12.4M 2026-03
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 1.8B 234M 2026-03
Mettler Toledo International USD 258.33M 1.5M 2026-03
Organigram Holdings CAD 22.01M 14.28M 2026-03
Ovoca Bio EUR 632K 2.33M 2025-06
Pharma Mar EUR 15.31M 2M 2026-03
Qiagen NV USD 153.88M 10.77M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Revvity USD 253.88M 2.15M 2026-03
Sartorius EUR 221.3M 500K 2026-03
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Tilray USD 24.85M 1.7M 2025-09
Trubridge Inc USD 51.62M 109.74M 2025-12
UnitedHealth USD 15.22B 1.44B 2025-09
Veeva Systems USD 126.47M 1.39M 2026-03
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 394M 153.99M 2026-03
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 214.31M 42.4M 2026-03